IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Affinity Asset Advisors, LLC

Q1 2022 Holdings

Filed 2022-05-13 | 59 holdings | $22.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Springworks Therapeutics IncCOM85205L107$13.9K247,0000.1%
Kura Oncology Inc(KURA)COM50127T109$14.9K924,1470.1%
Morphic Hldg IncCOM61775R105$18.7K465,6540.1%
Inari MED Inc(NARIUSD)COM45332Y109$19.9K220,0000.1%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$338.7K750,0001.5%
Context Therapeutics Inc(CNTX)COM21077P108$1.7M777,6107.5%
Aclaris Therapeutics Inc(ACRS)COM00461U105$1.7M100,0007.7%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$4.3M125,00019.0%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$14.1M120,00063.0%
PreviousPage 2 of 2